---
title: "Arvinas Inc reports results for the quarter ended December 31 - Earnings Summary"
date: "2025-02-11 22:32:12"
summary: "Arvinas Inc reported a quarterly adjusted loss of 63 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $-2.53. The mean expectation of twenty one analysts for the quarter was for a loss of $1.02 per share...."
categories:
  - "Reuters"
lang:
  - "en"
translations:
  - "en"
tags:
  - "Reuters"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

* Arvinas Inc reported a quarterly adjusted loss of 63 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $-2.53. The mean expectation of twenty one analysts for the quarter was for a loss of $1.02 per share. Wall Street expected results to range from $-1.87 to -22 cents per share.
* Revenue rose 237.4% to $59.20 million from a year ago; analysts expected $65.28 million.
* Arvinas Inc's reported EPS for the quarter was a loss of 63 cents​.
* The company reported a quarterly loss of $45.1 million.
* Arvinas Inc shares had fallen by 1.0% this quarter.

FORECAST CHANGES

* The mean earnings estimate of analysts had risen by about 6.1% in the last three months.​
* In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 20 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for Arvinas Inc is $60.00

This summary was machine generated from LSEG data February 11 at 02:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact [RefinitivNewsSupport@thomsonreuters.com](http://mailto:RefinitivNewsSupport@thomsonreuters.com))

| QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
| --- | --- | --- | --- |
| Dec. 31 2024 | -1.02 | -0.63 | Beat |
| Sep. 30 2024 | -0.96 | -0.68 | Beat |
| Jun. 30 2024 | -0.86 | -0.49 | Beat |
| Mar. 31 2024 | -1.42 | -0.97 | Beat |

[Reuters](https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3P21MJ:0-arvinas-inc-reports-results-for-the-quarter-ended-december-31-earnings-summary/)
